跳至主要内容
临床试验/ACTRN12620001184965
ACTRN12620001184965招募中未知

A multi-centre, randomised, controlled, non-inferiority trial in preterm infants with respiratory distress syndrome, comparing surfactant administration by supraglottic airway with minimally invasive surfactant therapy, assessing need for mechanical ventilation or repeat surfactant therapy within 72 hours of randomisation.

Monash Health0 个研究点目标入组 1,000 人开始时间: 2020年11月9日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
Monash Health
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
o limit 至 48 Hours(—)
性别
All

入选标准

  • Infants are eligible for inclusion in the trial if they meet all of the following criteria:
  • -Born preterm at less than 37 weeks’ gestation
  • -Birth weight 1250 g or above
  • -Age less than 48 hours
  • -Diagnosis of RDS, confirmed with chest x-ray or lung ultrasound, except where treatment is required urgently and would be delayed by imaging
  • -Required FiO2 0.30 or above to maintain target SpO2, on non-invasive respiratory support (CPAP/NIPPV or nHF)

排除标准

  • Infants are excluded from eligibility if they meet any of the following criteria:
  • -Previous treatment with surfactant or mechanical ventilation via an endotracheal tube
  • -Urgent need for intubation and mechanical ventilation as determined by the treating clinician
  • -Urgent need for surfactant prior to eligibility and consent criteria being met
  • -Known pneumothorax
  • -Major congenital anomaly of lungs, heart, or airway
  • -Not receiving full active intensive care (i.e. palliative/comfort care)

研究者

发起方
Monash Health

相似试验

已完成
不适用
High Flow Nasal Cannulae as Primary Support in the Treatment of Early Respiratory Distress (The HIPSTER Trial)
ACTRN12613000303741Professor Peter Davis750
终止
不适用
Trial of MRSA decolonisation treatment in adult hospital in-patientsMethicillin-resistant Staphylococcus aureus (MRSA) positive colonisationInfections and Infestations
ISRCTN12184897South Tees Hospitals NHS Foundation Trust32
已完成
不适用
A Randomized, Controlled, Multi-Center, Non-Inferiority Trial to Evaluate the Safety and Efficacy of Ultra-Low Frequency Spinal Cord Stimulation Compared to Traditional Spinal Cord Stimulation in Subjects with Chronic Back Pain with/without Leg Paiower Back PainLeg PainLower Back PainNeurological - Other neurological disordersMusculoskeletal - Other muscular and skeletal disorders
ACTRN12620000939998Presidio Medical AU, Pty Ltd91
进行中(未招募)
不适用
A multicenter, randomized, prospective, controlled study to evaluate the efficacy and the tolerability of a switch to a two different-dosed, nevirapine-based HAARTs in HIV-1 infected patients with undetectable plasma viremia. - SNODO
EUCTR2006-002582-39-ITFONDAZIONE NADIR ONLUS200
进行中(未招募)
不适用
A multi-centre, randomized, controlled, single-blinded, phase II study to investigate the safety and efficacy of intravenous infusions of FERINJECT® versus placebo in patients with thrombocytosis secondary to iron deficiency and chronic inflammatory bowel disease - ThromboVITPersons with Inflammatory Bowel Disease, thrombocytosis and iron deficiency
EUCTR2006-003328-12-ATVifor Int.